PATENT CLAIM ANALYSIS

Application Number: 15884608
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "093210"]

Abstract:
The presently disclosed subject matter provides for methods and compositions for treating cancer (e.g., multiple myeloma). It relates to anti-CD56 antibodies, chimeric antigen receptors (CARs) that specifically target human CD56, and immunoresponsive cells comprising such CARs. The presently disclosed CD56-specific CARs have enhanced immune-activating properties, including anti-tumor activity.

Claim (Index 31):
The CAR of  claim 30 , wherein the one co-stimulatory signaling region comprises a CD28 polypeptide.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.31111
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15368278', '15613800', '14805193', '14805075', '15511973']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7929204177968652
- 35 USC 102 Novelty (BERT): 0.6008324131733691
- Combined Prediction Score: 0.7737116173345155
- Mean Citation Score: 480.936978
- Max Citation Score: 561.69855
- Similarity Product: 459.4905166465133

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test